Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2025-11-18

Clinical Trial Update: Provide Pre-approval Single Patient Expanded Access (Compassionate Use) of Etrasimod for Patients.

View source ↗

Summary

Pfizer is providing pre-approval, single-patient expanded access (compassionate use) of etrasimod for ulcerative colitis, enabling treatment ahead of formal reg…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Etrasimod (etrasimod)

Snippet

Sponsor: Pfizer | Conditions: Colitis, Ulcerative | Status: AVAILABLE